A Krikorian

789 total citations
13 papers, 674 citations indexed

About

A Krikorian is a scholar working on Oncology, Pharmacology and Cell Biology. According to data from OpenAlex, A Krikorian has authored 13 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pharmacology and 3 papers in Cell Biology. Recurrent topics in A Krikorian's work include Cancer Treatment and Pharmacology (8 papers), Microtubule and mitosis dynamics (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). A Krikorian is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Microtubule and mitosis dynamics (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). A Krikorian collaborates with scholars based in France. A Krikorian's co-authors include F. Breillout, Arlette Fellous, M. Morimoto, J. P. Couzinier, S. CROS, Matthew C. Wright, Roger Rahmani, S. Brienza, Vincent Meininger and Stéphane Binet and has published in prestigious journals such as International Journal of Cancer, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

A Krikorian

13 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Krikorian France	13	538	174	164	81	73	13	674
Kathleen A. Havlin United States	11	588 1.1×	154 0.9×	121 0.7×	23 0.3×	42 0.6×	27	744
C.J. Bol Netherlands	8	391 0.7×	271 1.6×	87 0.5×	35 0.4×	46 0.6×	10	557
Ronald Drengler United States	13	487 0.9×	296 1.7×	104 0.6×	55 0.7×	56 0.8×	27	701
J. H. M. Schellens Netherlands	12	281 0.5×	156 0.9×	83 0.5×	36 0.4×	22 0.3×	18	506
I. Mandjes Netherlands	4	294 0.5×	94 0.5×	48 0.3×	42 0.5×	25 0.3×	4	408
Suzanne M. Fields United States	12	385 0.7×	167 1.0×	143 0.9×	18 0.2×	34 0.5×	15	610
M Volm Germany	13	459 0.9×	293 1.7×	126 0.8×	18 0.2×	22 0.3×	42	749
Joanna Regis United States	10	550 1.0×	270 1.6×	47 0.3×	31 0.4×	32 0.4×	14	660
Marcela Mrhalová Czechia	15	218 0.4×	316 1.8×	144 0.9×	35 0.4×	28 0.4×	48	594
Greta Cipriani Italy	7	325 0.6×	166 1.0×	87 0.5×	25 0.3×	69 0.9×	7	529

Countries citing papers authored by A Krikorian

Since Specialization

Citations

This map shows the geographic impact of A Krikorian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Krikorian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Krikorian more than expected).

Fields of papers citing papers by A Krikorian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Krikorian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Krikorian. The network helps show where A Krikorian may publish in the future.

Co-authorship network of co-authors of A Krikorian

This figure shows the co-authorship network connecting the top 25 collaborators of A Krikorian. A scholar is included among the top collaborators of A Krikorian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Krikorian. A Krikorian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Gamelin, Érick, M. Boisdron‐Celle, Alain Turcant, et al.. (1998). Determination of unbound platinum after oxaliplatin administration. Anti-Cancer Drugs. 9(3). 223–228. 12 indexed citations

Gamelin, Érick, Anne Le Bouil, M. Boisdron‐Celle, et al.. (1997). Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.. PubMed. 3(6). 891–9. 70 indexed citations

Brienza, S., J. Vignoud, M. Itzhaki, & A Krikorian. (1995). 933 Oxaliplatin (L-OHP®): Global safety in 682 patients (PTS). European Journal of Cancer. 31. S194–S194. 33 indexed citations

Urien, Saı̈k, et al.. (1993). Vinorelbine high-affinity binding to human platelets and lymphocytes: distribution in human blood. Cancer Chemotherapy and Pharmacology. 32(3). 231–234. 40 indexed citations

Krikorian, A & F. Breillout. (1991). Vinorelbine (Navelbine®). A New Semisynthetic Vinca Alkaloid. Oncology Research and Treatment. 14(1). 7–12. 25 indexed citations

Jehl, F., Élisabeth Quoix, Dominique Levêque, et al.. (1991). Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.. PubMed. 51(8). 2073–6. 68 indexed citations

Hecquet, B, Armelle Caty, M O Vilain, et al.. (1991). Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.. PubMed. 51(19). 5384–91. 17 indexed citations

Fellous, Arlette, et al.. (1990). Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules. International Journal of Cancer. 46(2). 262–266. 96 indexed citations

Besenval, M, et al.. (1989). Safety and tolerance of Navelbine in phase I-II clinical studies.. PubMed. 16(2 Suppl 4). 37–40. 31 indexed citations

10.

CROS, S., et al.. (1989). Experimental antitumor activity of Navelbine.. PubMed. 16(2 Suppl 4). 15–20. 117 indexed citations

11.

Krikorian, A, et al.. (1989). Pharmacokinetics and metabolism of Navelbine.. PubMed. 16(2 Suppl 4). 21–5. 73 indexed citations

12.

Binet, Stéphane, et al.. (1989). In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence.. PubMed. 16(2 Suppl 4). 5–8. 77 indexed citations

13.

Marty, M., et al.. (1989). Advances in vinca-alkaloids: Navelbine.. PubMed. 31(2). 77–84. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact